Axel W.A. Baltzer
Axel W.A. Baltzer has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Daniel Stosch
Associate Practice at Königsallee/Centre for Molecular Orthopaedics, Königsallee 53-55, Düsseldorf, 40212, Germany
3 shared publicationsMartin S. Ostapczuk
Clinic for Orthopaedics and Trauma Surgery, St. Josef Hospital, Asberger Str. 4, Moers, 47441, Germany
3 shared publicationsM. S. Ostapczuk
St. Josef Krankenhaus Moers
2 shared publicationsMarkus Granrath
Centre for Molecular Orthopaedics Düsseldorf; Kinios Clinic Düsseldorf
2 shared publicationsAlexei Korff
Center for Molecular Orthopaedics, MVZ Ortho Koenigsallee, Düsseldorf, Germany
1 shared publicationC. van Hauten
Klinik für Orthopädie und Unfallchirurgie, St. Elisabeth-Krankenhaus, Geilenkirchen
1 shared publication
Latest Publications
- Open Access
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 10
Biological injection therapy with leukocyte-poor platelet-rich plasma induces cellular alterations, enhancement of lubricin, and inflammatory downregulation in vivo in human knees: A controlled, prospective human clinical trial based on mass spectrometry imaging analysis
Objective: To investigate the in vivo biological effects of leukocyte-poor platelet-rich plasma (LpPRP) treatment in human synovial layer to establish the cellular basis for a prolonged clinical improvement.Methods: Synovial tissues (n = 367) were prospectively collected from patients undergoing arthroscopic surgery. Autologous-conditioned plasma, LpPRP, was injected into the knees of 163 patients 1–7 days before surgery to reduce operative trauma and inflammation, and to induce the onset of regeneration. A total of 204 patients did not receive any injection. All samples were analyzed by mass spectrometry imaging. Data analysis was evaluated by clustering, classification, and investigation of predictive peptides. Peptide identification was done by tandem mass spectrometry and database matching.Results: Data analysis revealed two major clusters belonging to LpPRP-treated (LpPRP-1) and untreated (LpPRP-0) patients. Classification analysis showed a discrimination accuracy of 82%–90%. We identified discriminating peptides for CD45 and CD29 receptors (receptor-type tyrosine-protein phosphatase C and integrin beta 1), indicating an enhancement of musculoskeletal stem cells, as well as an enhancement of lubricin, collagen alpha-1-(I) chain, and interleukin-receptor-17-E, dampening the inflammatory reaction in the LpPRP-1 group following LpPRP injection.Conclusions: We could demonstrate for the first time that injection therapy using “autologic-conditioned biologics” may lead to cellular changes in the synovial membrane that might explain the reported prolonged beneficial clinical effects. Here, we show in vivo cellular changes, possibly based on muscular skeletal stem cell alterations, in the synovial layer. The gliding capacities of joints might be improved by enhancing of lubricin, anti-inflammation by activation of interleukin-17 receptor E, and reduction of the inflammatory process by blocking interleukin-17.
- 21 April 2023
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 10
Open AccessBiological injection therapy with leukocyte-poor platelet-rich plasma induces cellular alterations, enhancement of lubricin, and inflammatory downregulation in vivo in human knees: A controlled, prospective human clinical trial based on mass spectrometry imaging analysis
Objective: To investigate the in vivo biological effects of leukocyte-poor platelet-rich plasma (LpPRP) treatment in human synovial layer to establish the cellular basis for a prolonged clinical improvement.Methods: Synovial tissues (n = 367) were prospectively collected from patients undergoing arthroscopic surgery. Autologous-conditioned plasma, LpPRP, was injected into the knees of 163 patients 1–7 days before surgery to reduce operative trauma and inflammation, and to induce the onset of regeneration. A total of 204 patients did not receive any injection. All samples were analyzed by mass spectrometry imaging. Data analysis was evaluated by clustering, classification, and investigation of predictive peptides. Peptide identification was done by tandem mass spectrometry and database matching.Results: Data analysis revealed two major clusters belonging to LpPRP-treated (LpPRP-1) and untreated (LpPRP-0) patients. Classification analysis showed a discrimination accuracy of 82%–90%. We identified discriminating peptides for CD45 and CD29 receptors (receptor-type tyrosine-protein phosphatase C and integrin beta 1), indicating an enhancement of musculoskeletal stem cells, as well as an enhancement of lubricin, collagen alpha-1-(I) chain, and interleukin-receptor-17-E, dampening the inflammatory reaction in the LpPRP-1 group following LpPRP injection.Conclusions: We could demonstrate for the first time that injection therapy using “autologic-conditioned biologics” may lead to cellular changes in the synovial membrane that might explain the reported prolonged beneficial clinical effects. Here, we show in vivo cellular changes, possibly based on muscular skeletal stem cell alterations, in the synovial layer. The gliding capacities of joints might be improved by enhancing of lubricin, anti-inflammation by activation of interleukin-17 receptor E, and reduction of the inflammatory process by blocking interleukin-17.
- Open Access
- 1 January 2021
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 13 (1)
Magnetic resonance imaging and clinically controlled improvement of a combined autologous conditioned plasma combined with rh collagen type I injections in lateral epicondylitis
The purpose of the study was to investigate the effect of combined autologous conditioned plasma and recombinant human collagen type I injections on lateral epicondylitis. Outcome was measured in 5 patients before the single application of ACP+rhCollagen type I (Arthrex ACP (R) Tendo) and after 10.60 +/- 3.58wks by means of (i) the Visual Analogue Scale for pain, (ii) range of motion for wrist extension/flexion as well as supination/pronation, and (iii) MRI-scans. VAS-scores significantly decreased from 6.40 +/- 1.14 at baseline to 1.80 +/- 2.49 at follow-up, and the effect was very large (p=0.04, dz=2.22). In addition, range of motion either improved or remained unrestricted, and MRI-scans showed healing of the extensor carpi radialis brevis tendon in most cases. A combined ACP+rhCollageninjection successfully reduces pain in lateral epicondylitis. Due to the small sample size, however, these promising preliminary results need further investigation in future research.
- 1 January 2021
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 13 (1)
Open AccessMagnetic resonance imaging and clinically controlled improvement of a combined autologous conditioned plasma combined with rh collagen type I injections in lateral epicondylitis
The purpose of the study was to investigate the effect of combined autologous conditioned plasma and recombinant human collagen type I injections on lateral epicondylitis. Outcome was measured in 5 patients before the single application of ACP+rhCollagen type I (Arthrex ACP (R) Tendo) and after 10.60 +/- 3.58wks by means of (i) the Visual Analogue Scale for pain, (ii) range of motion for wrist extension/flexion as well as supination/pronation, and (iii) MRI-scans. VAS-scores significantly decreased from 6.40 +/- 1.14 at baseline to 1.80 +/- 2.49 at follow-up, and the effect was very large (p=0.04, dz=2.22). In addition, range of motion either improved or remained unrestricted, and MRI-scans showed healing of the extensor carpi radialis brevis tendon in most cases. A combined ACP+rhCollageninjection successfully reduces pain in lateral epicondylitis. Due to the small sample size, however, these promising preliminary results need further investigation in future research.
- 2 May 2017
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 76 (9) , 806-812
Low-Level-Lasertherapie
- 2 May 2017
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 76 (9) , 806-812
Low-Level-Lasertherapie
- 2 February 2016
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 48 (5) , 498-504
Positive effects of low level laser therapy (LLLT) on Bouchard's and Heberden's osteoarthritis
Background and Objective Osteoarthritis (OA) is a common chronic disorder. While research usually focuses on OA of the large joints, OA of the hand receives relatively little attention resulting in a lack of a therapeutic gold standard. Low level laser therapy (LLLT)/photobiomodulation therapy has been successfully used to treat a variety of medical conditions. Nevertheless, its merits in the treatment of (hand) OA remain controversial. The aim of the present study was to examine the longitudinal effect of LLLT on the three major hand OA symptoms—pain, swelling, reduced joint mobility—in patients suffering from Bouchard's and Heberden's OA. Study Design/Materials and Methods Thirty-four patients (32 females) aged 61.21 ± 2.13 years were administered 5–10 LLLT sessions to 85 joints (47 proximal and 38 distal interphalangeal joints). Therapy took place twice a week. Pain (Visual Analogue Scale), ring size (perimeter in mm), and range of motion (extension/flexion) were measured at baseline and after five treatments for all patients, and additionally after seven sessions and 8 weeks after treatment ended for patients who received more than five and seven treatments, respectively. Eighteen patients (37 joints) received only five treatments, 10 patients (29 joints) were administered seven treatments, and six patients (19 joints) were administered 10 LLLT sessions. Results LLLT significantly reduced pain and ring size and increased range of motion after five and seven treatments (all P's < 0.001). The effects were very large (all η2's > 0.14). No further significant change occurred between 7 and 10 treatments. The effects achieved after seven sessions persisted for 8 weeks. Conclusions LLLT is a safe, non-invasive, efficient and efficacious means to reduce pain and swelling and to increase joint mobility in patients suffering from Heberden's and Bourchard's OA. Further randomized controlled studies are needed to examine medium- to long-term effects as well as the ideal LLLT parameters. Lasers Surg. Med.
- 2 February 2016
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 48 (5) , 498-504
Positive effects of low level laser therapy (LLLT) on Bouchard's and Heberden's osteoarthritis
Background and Objective Osteoarthritis (OA) is a common chronic disorder. While research usually focuses on OA of the large joints, OA of the hand receives relatively little attention resulting in a lack of a therapeutic gold standard. Low level laser therapy (LLLT)/photobiomodulation therapy has been successfully used to treat a variety of medical conditions. Nevertheless, its merits in the treatment of (hand) OA remain controversial. The aim of the present study was to examine the longitudinal effect of LLLT on the three major hand OA symptoms—pain, swelling, reduced joint mobility—in patients suffering from Bouchard's and Heberden's OA. Study Design/Materials and Methods Thirty-four patients (32 females) aged 61.21 ± 2.13 years were administered 5–10 LLLT sessions to 85 joints (47 proximal and 38 distal interphalangeal joints). Therapy took place twice a week. Pain (Visual Analogue Scale), ring size (perimeter in mm), and range of motion (extension/flexion) were measured at baseline and after five treatments for all patients, and additionally after seven sessions and 8 weeks after treatment ended for patients who received more than five and seven treatments, respectively. Eighteen patients (37 joints) received only five treatments, 10 patients (29 joints) were administered seven treatments, and six patients (19 joints) were administered 10 LLLT sessions. Results LLLT significantly reduced pain and ring size and increased range of motion after five and seven treatments (all P's < 0.001). The effects were very large (all η2's > 0.14). No further significant change occurred between 7 and 10 treatments. The effects achieved after seven sessions persisted for 8 weeks. Conclusions LLLT is a safe, non-invasive, efficient and efficacious means to reduce pain and swelling and to increase joint mobility in patients suffering from Heberden's and Bourchard's OA. Further randomized controlled studies are needed to examine medium- to long-term effects as well as the ideal LLLT parameters. Lasers Surg. Med.
- Open Access
- 7 June 2013
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 5 (2) , e13-64
A new treatment for hip osteoarthritis: clinical evidence for the efficacy of autologous conditioned serum
The purpose of the present study was to investigate the effect of intra-articular injections of autologous conditioned serum on human hip osteoarthritis and to test whether a potential treatment effect might be increased by additional injections of steroids and the recombinant interleukin-1 receptor antagonist protein anakinra. We compared the effects of autologous conditioned serum 46 hip osteoarthritis patients), autologous conditioned serum+cortisone (56 patients), and autologous conditioned serum+cortisone+recombinant interleukin-1 receptor antagonist protein (17 patients) in a retrospective clinical study by means of the Visual Analogue Scale for pain (pre- vs post-treatment). Over 14 months, treatment resulted in a large, statistically significant improvement for patients in all three groups, independent of the severity of osteoarthritis. Neither cortisone nor cortisone+recombinant interleukin-1 receptor antagonist protein increased the beneficial treatment effect over and above the effect of autologous conditioned serum alone. Autologous conditioned serum successfully reduces pain in hip osteoarthritis. In severe hip osteoarthritis, the sole application of autologous conditioned serum can be even more beneficial than the combination of autologous conditioned serum with steroids.
- 7 June 2013
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 5 (2) , e13-64
Open AccessA new treatment for hip osteoarthritis: clinical evidence for the efficacy of autologous conditioned serum
The purpose of the present study was to investigate the effect of intra-articular injections of autologous conditioned serum on human hip osteoarthritis and to test whether a potential treatment effect might be increased by additional injections of steroids and the recombinant interleukin-1 receptor antagonist protein anakinra. We compared the effects of autologous conditioned serum 46 hip osteoarthritis patients), autologous conditioned serum+cortisone (56 patients), and autologous conditioned serum+cortisone+recombinant interleukin-1 receptor antagonist protein (17 patients) in a retrospective clinical study by means of the Visual Analogue Scale for pain (pre- vs post-treatment). Over 14 months, treatment resulted in a large, statistically significant improvement for patients in all three groups, independent of the severity of osteoarthritis. Neither cortisone nor cortisone+recombinant interleukin-1 receptor antagonist protein increased the beneficial treatment effect over and above the effect of autologous conditioned serum alone. Autologous conditioned serum successfully reduces pain in hip osteoarthritis. In severe hip osteoarthritis, the sole application of autologous conditioned serum can be even more beneficial than the combination of autologous conditioned serum with steroids.
- 25 April 2013
- Published by Georg Thieme Verlag KG in Zeitschrift für Orthopädie und Unfallchirurgie
- Vol. 151 (02) , 142-148
Sonografische Dimensionen der Patellasehne von Hochleistungssportlern
Hintergrund: Die sonografische Wertigkeit der Sehnenverdickung als morphologisches Korrelat der patellaren Tendinopathie gilt zumindest an der proximalen Insertion des Lig. patellae als unumstritten. Es fehlen jedoch verbindliche Grenzwerte für Leistungssportler und Normalpersonen. Darüber hinaus herrscht in der Literatur nach wie vor Uneinigkeit über die klinische Relevanz von qualitativen Veränderungen wie z. B. der Hypoechogenität der Sehnenbinnenstruktur. Probanden: 202 Kaderathleten des Deutschen Leichtathletik-Verbandes und 199 altersgematchte Normalpersonen wurden sonografisch untersucht. Methoden: 404 Patellasehnen von Leistungssportlern wurden mittels des tragbaren Ultraschallgeräts „Just Vision“ mit 398 Patellasehnen von Normalpersonen bezüglich der Sehnendicke an der (i) proximalen Insertion, der (ii) Taille und der (iii) distalen Insertion verglichen. Zusätzlich wurden qualitative pathologische Veränderungen und klinische Beschwerden erfasst. Ergebnisse: Die Athleten berichteten über mehr klinische Beschwerden und ihre Patellasehnen waren an allen 3 Messpositionen dicker als die der Normalpersonen (alle p-Werte < 0,01). Ab einer proximalen Insertionsdicke von 6,0 mm war bei den Sportlern mit hoher Sicherheit von klinischen Beschwerden auszugehen. Bei den Athleten war an allen 3 Messpositionen ein Zusammenhang zwischen Dicke und Symptomatik zu verzeichnen, in der Kontrollgruppe war dies nur an der proximalen Insertion der Fall. Qualitativ zeigten sich wenig konsistente Unterschiede zwischen Kader- und Kontrollgruppe. Schlussfolgerung: Das Ergebnismuster bestätigt die klinische Relevanz der proximalen Insertionsdicke für die patellare Tendinopathie und liefert kritische Grenzwerte, die zukünftig hinsichtlich ihrer Prognosefunktion im Leistungssport weiter untersucht werden sollten. Die Bedeutung von qualitativ-pathologischen Veränderungen wie Hypoechogenität konnte nicht sicher belegt werden. Background: The sonographic validity of a thickened tendon as a morphological correlate of patellar tendinopathy is beyond dispute, regarding the proximal insertion at the very least. There is, however, a lack of mandatory standard values for competitive athletes and normal individuals. In addition, research findings concerning the clinical relevance of qualitative changes such as hypoechogenic regions are still inconclusive. Participants: 202 national squad athletes from the German track and field federation and 199 age-matched normal individuals were examined sonographically. Method: 404 patellar tendons of athletes were compared as to tendon diameter at the (i) proximal insertion, (ii) waist, and (iii) distal insertion with 398 patellar tendons of normal individuals using the portable ultrasound scanner “Just Vision”. Furthermore, qualitative pathologies and clinical symptoms were assessed. Results: Athletes reported more clinical symptoms and their tendons were thicker than normal tendons at all three positions (all pʼs < 0.01). In athletes, proximal diameters above 6.0 mm were very likely to go along with clinical symptoms. There was an association between tendon diameter and symptoms at all three positions among the athletes, whereas in controls, this was only true for the proximal insertion. Only few consistent qualitative differences were found between athletes and normal individuals. Conclusion: The pattern of results confirms the clinical relevance of the proximal tendon diameter for patellar tendinopathy and provides standard values which should be evaluated in future research with regard to their prognostic utility in competitive sports. The importance of qualitative pathologies such as hypoechogenic regions could not be firmly asserted.
- 25 April 2013
- Published by Georg Thieme Verlag KG in Zeitschrift für Orthopädie und Unfallchirurgie
- Vol. 151 (02) , 142-148
Sonografische Dimensionen der Patellasehne von Hochleistungssportlern
Hintergrund: Die sonografische Wertigkeit der Sehnenverdickung als morphologisches Korrelat der patellaren Tendinopathie gilt zumindest an der proximalen Insertion des Lig. patellae als unumstritten. Es fehlen jedoch verbindliche Grenzwerte für Leistungssportler und Normalpersonen. Darüber hinaus herrscht in der Literatur nach wie vor Uneinigkeit über die klinische Relevanz von qualitativen Veränderungen wie z. B. der Hypoechogenität der Sehnenbinnenstruktur. Probanden: 202 Kaderathleten des Deutschen Leichtathletik-Verbandes und 199 altersgematchte Normalpersonen wurden sonografisch untersucht. Methoden: 404 Patellasehnen von Leistungssportlern wurden mittels des tragbaren Ultraschallgeräts „Just Vision“ mit 398 Patellasehnen von Normalpersonen bezüglich der Sehnendicke an der (i) proximalen Insertion, der (ii) Taille und der (iii) distalen Insertion verglichen. Zusätzlich wurden qualitative pathologische Veränderungen und klinische Beschwerden erfasst. Ergebnisse: Die Athleten berichteten über mehr klinische Beschwerden und ihre Patellasehnen waren an allen 3 Messpositionen dicker als die der Normalpersonen (alle p-Werte < 0,01). Ab einer proximalen Insertionsdicke von 6,0 mm war bei den Sportlern mit hoher Sicherheit von klinischen Beschwerden auszugehen. Bei den Athleten war an allen 3 Messpositionen ein Zusammenhang zwischen Dicke und Symptomatik zu verzeichnen, in der Kontrollgruppe war dies nur an der proximalen Insertion der Fall. Qualitativ zeigten sich wenig konsistente Unterschiede zwischen Kader- und Kontrollgruppe. Schlussfolgerung: Das Ergebnismuster bestätigt die klinische Relevanz der proximalen Insertionsdicke für die patellare Tendinopathie und liefert kritische Grenzwerte, die zukünftig hinsichtlich ihrer Prognosefunktion im Leistungssport weiter untersucht werden sollten. Die Bedeutung von qualitativ-pathologischen Veränderungen wie Hypoechogenität konnte nicht sicher belegt werden. Background: The sonographic validity of a thickened tendon as a morphological correlate of patellar tendinopathy is beyond dispute, regarding the proximal insertion at the very least. There is, however, a lack of mandatory standard values for competitive athletes and normal individuals. In addition, research findings concerning the clinical relevance of qualitative changes such as hypoechogenic regions are still inconclusive. Participants: 202 national squad athletes from the German track and field federation and 199 age-matched normal individuals were examined sonographically. Method: 404 patellar tendons of athletes were compared as to tendon diameter at the (i) proximal insertion, (ii) waist, and (iii) distal insertion with 398 patellar tendons of normal individuals using the portable ultrasound scanner “Just Vision”. Furthermore, qualitative pathologies and clinical symptoms were assessed. Results: Athletes reported more clinical symptoms and their tendons were thicker than normal tendons at all three positions (all pʼs < 0.01). In athletes, proximal diameters above 6.0 mm were very likely to go along with clinical symptoms. There was an association between tendon diameter and symptoms at all three positions among the athletes, whereas in controls, this was only true for the proximal insertion. Only few consistent qualitative differences were found between athletes and normal individuals. Conclusion: The pattern of results confirms the clinical relevance of the proximal tendon diameter for patellar tendinopathy and provides standard values which should be evaluated in future research with regard to their prognostic utility in competitive sports. The importance of qualitative pathologies such as hypoechogenic regions could not be firmly asserted.
- Open Access
- 2 January 2012
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 4 (1) , e4
The use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy
Although the clinical potential of bone morphogenetic proteins (BMPs) has been known for decades, their use in humans has only been approved for a limited number of orthopaedic conditions. Promising results in animals demonstrate the utility of BMP-2 in regional bone repair without using osteoconductors. To our knowledge, no comparable human case has been described. We report the case of a 50- year-old who suffered a femoral neck fracture. After 9 months of extensive treatment, he was still not pain-free. The following open-wedge osteotomy resulted in a therapy-resistant delayed union. We therefore conducted 4 computer tomography-guided injections of recombinant human (rh) BMP-2 into the bone gap. No osteoconductor was employed. Six weeks later, there was a 55-60% defect filling. Followup examination showed a complete union of the bone defect. Our case report shows that in a complicated delayed union rhBMP-2 can be successfully used to induce bone formation without any osteoconductor.
- 2 January 2012
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 4 (1) , e4
Open AccessThe use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy
Although the clinical potential of bone morphogenetic proteins (BMPs) has been known for decades, their use in humans has only been approved for a limited number of orthopaedic conditions. Promising results in animals demonstrate the utility of BMP-2 in regional bone repair without using osteoconductors. To our knowledge, no comparable human case has been described. We report the case of a 50- year-old who suffered a femoral neck fracture. After 9 months of extensive treatment, he was still not pain-free. The following open-wedge osteotomy resulted in a therapy-resistant delayed union. We therefore conducted 4 computer tomography-guided injections of recombinant human (rh) BMP-2 into the bone gap. No osteoconductor was employed. Six weeks later, there was a 55-60% defect filling. Followup examination showed a complete union of the bone defect. Our case report shows that in a complicated delayed union rhBMP-2 can be successfully used to induce bone formation without any osteoconductor.